Skip to main content

Prevalence, distribution and antimicrobial susceptibility pattern of bacterial isolates from a tertiary Hospital in Malawi

Abstract

Background

Bacterial infections are a significant cause of sickness and death in sub-Saharan Africa. This study aimed at establishing the prevalence, distribution and antimicrobial susceptibility pattern of major bacterial isolates from patients accessing medical care at a tertiary hospital in Malawi.

Methods

We retrospectively reviewed bacteria culture and antimicrobial susceptibility records for 4617 patients from 2002 to 2014 at Mzuzu Central Hospital (MCH). No inclusion and exclusion criteria were followed. Data was analysed using excel (Microsoft office, USA) and GraphPad prism 7 software programs.

Results

The most prevalent isolates were S. aureus (34.7%, n = 783), Klebsiella species (17.4%, n = 393) and Proteus species (11.4%, n = 256). Most microorganisms were isolated from adults (88.3%, n = 3889) and pus was the main source (69.3%, n = 1224). S. pneumoniae was predominantly isolated from cerebrospinal fluid (60.3%, n = 44) largely collected from children (88.2%, n = 64). Overall, most bacteria exhibited high resistance to all regularly used antimicrobials excluding ciprofloxacin.

Conclusions

Our report demonstrates an increase in bacterial infection burden in sites other than blood stream and subsequent increase in prevalence of antimicrobial resistance for all major isolates. Creating an epidemiological survey unit at MCH will be essential to help inform better treatment and management options for patients with bacterial infections.

Peer Review reports

Background

Bacterial diseases remain the major cause of morbidity and mortality worldwide [1]. Infectious diseases are predominant in Africa and are largely influenced by vulnerable population, social inequality and poor health delivery systems [1]. Inadequate funding, poor microbiology services, limited technical experts and scarce epidemiological data to inform better preventive and treatment strategies all contribute to the rise in burden of bacterial infections in Africa [2, 3]. This increase in the burden of bacterial infections is also accompanied by high incidences of antimicrobial resistance (AMR) [4]. As a low income country in Africa, Malawi is no exception to these challenges [5].

Across Africa, AMR has been reported in different countries. Apart from the emergence of Methicillin-resistant Staphylococcus aureus (MRSA), Malawi has reported a rapid increase in non-Salmonella Enterobacteriaceae with extended spectrum beta-lactamase (ESBL) and fluoroquinolone resistance among common Gram-negative pathogens [5]. In Zimbabwe, Gram-negative bacteria showed high resistance to cotrimoxazole (68.5%) and ampicillin (84.5%) while Gram-positive bacteria demonstrated resistance to cotrimoxazole (69%) and Nalidixic acid (81%) [6]. A study in Ghana revealed that Neisseria gonorrhoeae isolates were resistant to tetracycline (100%), benzylpenicillin (90.9%) and ciprofloxacin (88.6%) [7]. In general, important Gram-negative bacteria including Klesbsiella, E. coli, Salmonella, Shigella and Gram-positive bacteria such as S. pneumoniae, S. aureus, S. agalactae, (MRSA) across Africa have acquired resistance to the common essential antimicrobials being used in the region [8].

The rise in AMR has been attributed to several factors such as bad clinical practices, poor public perception and behaviour towards antimicrobial use, increase in adverse agricultural practices etc. [9]. Most importantly, irresponsible widespread use of antimicrobials creates a sturdy selective pressure that propels the adaptive and evolutionary response by microbes, hence the emergence of various AMR phenotypes [9]. Worse still, today’s global economy allows people to travel and interact worldwide which enables transmission and spread of pathogens worldwide [9]. The rise in AMR not only threatens the public health sector but also the already fragile economies in the African continent through prolonged hospitalization and use of expensive and specialised treatment and care for the sick.

It is generally accepted that AMR is a global threat mostly affecting low-income countries, however most data available on bacterial pathogen surveillance and AMR profile is from high-income countries [8]. Nevertheless, in Africa, many countries use syndromic approaches to treat bacterial infections. In order to be effective, empirical treatment requires better knowledge of local AMR profiles. The aim of this study was to determine the prevalence, distribution and antimicrobial susceptibility patterns of commonly isolated pathogenic bacteria at Mzuzu Central Hospital (MCH), a referral hospital for six district hospitals in the Northern region of Malawi.

Methodology

Research design

We conducted a retrospective audit of records for bacterial culture and susceptibility testing results between the years 2002 and 2014 from MCH microbiology laboratory department. No inclusion and exclusion criteria were applied. The MCH Laboratory participates in international microbiology quality assessment programs such as the UK External Quality Assessment program (UKNEQAS) and Zimbabwe Quality Assurance Program (ZIMQAP). Ethical approval for the study was obtained from National Health Science Research Committee (NHSRC; approval number NHSRC # 1206).

Bacterial identification and characterisation

Specimens from outpatient department and clinical wards were transported to microbiology department laboratory for analysis within 2 h of collection. Conventional microbiological culture methods were employed to isolate and identify bacteria. Media was prepared in-house as per procedures stipulated in Cheesbrough [10].

About 10 mL and 3 mL of blood collected from adults and paediatric patients, respectively were inoculated into BD Bactec plus aerobic culture vials™ for incubation at 35–37 °C in BD Bactec™ 9050 Blood Culture System (BD, USA). Positive cultures were sub-cultured onto Blood Agar Plate (BAP), MacConkey Agar Plate (MAP) or Chocolate Agar Plate (CAP) if any fastidious organism was suspected. Inoculated plates were incubated at 37 °C, 5% CO2 for up to 72 h.

Swabs collected from wounds, skin and soft tissue infection were Gram stained, cultured on either BAP/CAP or MAP, and, incubated at 37 °C,5% CO2 for up to 72 h [10]. Swabs collected from cerebrospinal fluid (CSF) and other fluids, were Gram stained, cultured on BAP and CAP for incubation at 37 °C,5% CO2 for up to 72 h [10]. Urine samples were inoculated on CLED agar and incubated at 37 °C for up to 48 h [10]. A specimen was considered positive for urinary tract infection (UTI) if the number of enumerated colonies were greater than ≥105 CFU/mL [10, 11].

Isolates were identified and processed according to standard techniques summarised in Table 1. Antibiotic susceptibility was determined by disc diffusion technique on Mueller -Hinton agar except for Streptococcus pneumonia and other fastidious organisms, the Mueller-Hinton agar was supplemented with 5% human blood (from blood donors). Data was interpreted according to the CLSI guidelines with quality-controlled strains; Escherichia coli ATCC 25922 and Staphylococcus aureus ATCC 25923 [12]. Major bacterial isolates were evaluated for their susceptibility against the most commonly used antimicrobials during the study period. Antimicrobial screening was performed with the following antibiotics: ciprofloxacin, ceftriaxone, penicillin, tetracycline, ampicillin, chloramphenicol, amoxicillin, and gentamicin.

Table 1 Laboratory methods for bacteria identification and susceptibility testing

Data analysis

Data was analysed using Excel (Microsoft office, USA) and GraphPad Prism 7 software (San Diego, CA, USA). Graphs or pie chart were used to show the prevalence and distribution of the isolated bacteria against gender (male and female), age groups (Children and adults) and specimens (Pus, ear swab, V. Blood, Cerebral Spinal Fluids, High Vaginal Swabs, Urine and Other fluids). In addition, a frequency table expressed in percentage and absolute numbers was used to display the susceptibility patterns of the six commonly isolated bacteria against the six commonly used antibiotics.

Results

Study population and demographics

To understand the demographics of the patient population, clients were characterised according to their sex and age group. Out of 4617 patients who submitted samples for microbial analysis, 2246 (49%) were male and 2371 (51%) were female (Fig. 1). We observed that 84% (n =3889) were adult patients (> 12 years old) while were 11% (n =517) were children (≤12 years old) (Fig. 1).

Fig. 1
figure1

Demographics of the study population. Patients were categorised by gender and age group

Fig. 2
figure2

Distribution of isolates by specimen source and hospital department. Absolute number of (a) specimens and (b) isolates recovered per department were determined

Analysis of isolates by source of specimen and hospital department

To analyse the dynamics of bacterial infections, total number of specimens collected and isolates recovered were determined for each hospital department. Most samples were collected in the Out Patient Department (OPD;1885, 43%; Fig. 2a). Pus from wound and ear infections were the most frequent samples and the majority of them were collected in the OPD, male surgical ward, paediatric ward and female surgical ward (Fig. 2a). Corresponding to the high number of samples collected, the OPD had the highest number of bacterial isolates (784, 44.5%; Fig. 2a). TB ward had the least number of isolates (20, 1.1%). Across the departments, S. aureus was the most isolated pathogen (783, 43.5%) followed by Klebsiella species (387, 22%) (Fig. 2b).

Prevalence of bacterial isolates

To evaluate the prevalence of bacteria pathogens over the study period, we determined the overall numbers of individual isolates and established the comprehensive figure of pathogens per year. Staphylococcus aureus was the most commonly isolated bacterium (783, 34.7%) (Fig. 3a). Other common isolates included Klebsiella species (393, 17.4%), Proteus species (256, 11.4%), Coagulase-Negative Staphylococcus (193, 8.6%), Escherichia coli (169, 7.5%) and Pseudomonas species (131, 5.8%; Fig. 3a). The pattern of number of patients over the years matched the pattern of positive cultures. As the number of patients increased or decreased so did the number of positive cultures (Fig. 3b). Altogether, the culture positivity rate was approximately 48.9% (2258/4611). Assuming that each patient submitted one sample, the highest culture positivity rate was recorded in 2011 (212/367; 57.7%) whereas the lowest rate was registered in 2005 (85/284; 29.9%; Fig. 3c). In 2011, 54.2% (115/212) of the bacteria isolates were gram negative with Klebsiella species being dominant (25/115; 21.7%).

Fig. 3
figure3

Prevalence of bacterial pathogens over the 13-year period. a Shows the prevalence of isolates during the study period. b Describes the distribution of patients alongside positive cultures throughout the study period. c Demonstrate the culture positivity rates in different years of the investigation period

Distribution of bacterial isolates according to demographics

To identify the most susceptible group from bacterial infections, isolates were distributed according to gender and age groups of the patients. The percentage of male and female patients whose samples were positive for bacterial culture was roughly the same i.e. 51 and 49% respectively (Fig. 4a). A significant number of bacterial isolates were isolated from patients aged more than 12 years (Fig. 4b). Largely, the distribution of isolates among male and females was fairly similar with prevalence rates of within 50% except for Pseudomonas species which were isolated more in males than females (63.1, 36.9% respectively; Fig. 4a). Most of the isolates were recovered from patients older than 12 years except S. pneumoniae which was isolated predominantly in clients younger than 12 years (88.2%; Fig. 4b).

Fig. 4
figure4

Prevalence of bacterial isolates per gender and age group. Isolated bacteria were distributed according to sex (a) and age group (b) of the patients

Antimicrobial susceptibility profiles of major bacterial isolates

To assess antimicrobial susceptibility, most commonly isolated bacteria were tested for their susceptibility to the most commonly used antimicrobials at the hospital during the 13-year period. In comparison to other pathogens, S. pneumoniae demonstrated the highest rate of susceptibility to most of the antibiotics except for gentamicin where 40% of the strains showed resistance (Table 2). In this study, ciprofloxacin followed by gentamicin and cotrimoxazole proved to be the most effective antimicrobials with overall pathogen susceptibility rates of 84, 75 and 70% respectively (Table 2). Nonetheless, worrying levels of antimicrobial resistance was registered in the study. On the whole, Pseudomonas species exhibited relatively the highest resistance to most antibiotics. Overall, high rates of antimicrobial resistance to erythromycin (49%), chloramphenicol (47%), and nalidixic acid (42%) were recorded (Table 1).

Table 2 Antimicrobial susceptibility patterns of major bacterial pathogens against commonly used antimicrobials during 2002–2014 period. The numbers in the table represent isolates found to be susceptible and resistant to the antimicrobials

Discussion

Understanding distribution of microbial pathogens and their associated infections is essential for controlling infectious diseases and monitoring of antimicrobial resistance. The current study aimed at establishing the prevalence of common pathogenic bacteria including their antimicrobial susceptibility patterns and distribution according to specimens, age groups and sex at Mzuzu Central hospital. We report a high prevalence of bacteria isolates with variability in susceptibility to key antimicrobials used during the study period. Most isolates displayed high resistance to erythromycin, gentamicin, chloramphenicol, nalidixic acid and cotrimoxazole. Conversely, majority of the isolates were sensitive to ciprofloxacin.

While a significant number of similar studies in Malawi were limited to investigating blood stream bacterial infections [5, 13,14,15,16,17,18], our study demonstrated the spread of bacterial infections where other body sites were surveyed (Fig. 2a-b). The high prevalence of bacteria isolates observed in this study (Fig. 3a) highlights the need for effective monitoring and surveillance of bacterial infections in resource-limited health care settings. There was a sharp decrease in number of isolates tested between 2003 and 2006 (Fig. 3b), followed by a slow appreciation in subsequent years. Among other reasons, we suggest that this might have been as a result of reduced capacity of the laboratory to perform microbiology testing services. In 2004, the Malawi government had parted ways with a major donor supporting services at Mzuzu Central Hospital. Several services including laboratory services were negatively affected until a few years later when the government devised ways to fill the gap.

Similar to previous investigations [19,20,21,22,23,24], our findings revealed that S. aureus was the predominant cause of bacterial infections (Fig. 3a). S. aureus is the common cause of skin and soft tissue infections [25, 26]. Hence it is not surprising that we observed considerably high number of isolates from OPD, male surgical ward and female surgical ward following culture of pus obtained from wound and surgical site infections. The subsequent prevalent pathogens in the study were Klebsiella and Proteus species (Fig. 3a), which were also mostly recovered from wound pus. Likewise, this observation is comparable to investigations conducted in other countries [22, 23, 26,27,28].

The fluctuations in the number of patients that were provided with microbiology services correspond with the number of positive cultures. As the number of patients increased, positive cultures also increased and vice versa (Fig. 3b). The relatively high bacterial culture positivity rates observed (Fig. 3c) in this study could suggest good culture and bacterial isolation techniques. On the other hand, this could also be as a result of more contaminants being isolated, as most of the isolates i.e. S. aureus were isolated from pus, which can easily be contaminated with skin flora.

Except for S. pneumoniae most of the pathogens were isolated from patients > 12 years old and adult patients (Fig. 4b). The study registered more adults than children hence the observation that more isolates were recovered from adults corresponds with the high number of adult clients registered. S. pneumoniae is a common cause of bacterial meningitis in children [29], as such, our finding is consistent with literature. Correspondingly, our study showed that S. pneumoniae was predominantly isolated from CSF largely collected from children.

In general, all major isolates showed relatively high resistance to essential antimicrobials used during the study period (Table 2). Similar to previous studies [19, 30], our investigation showed higher rates of S. aureus resistance to chloramphenicol and erythromycin. Methicillin-resistant Staphylococcus aureus (MRSA) has significantly contributed to antimicrobial resistance globally [31], hence the drawback in this investigation is that S. aureus isolates were not tested to determine if some of the isolates were of MRSA origin.

S. pneumonia is a significant cause of pneumonia, sepsis, bacterial meningitis and death in Malawian children and adults [32,33,34,35]. Chloramphenicol is one of the antibiotics used in the treatment of bacterial meningitis including invasive pneumococcal diseases in Malawi. Previous investigations in Malawi reported higher rates of S. pneumoniae resistance to chloramphenicol which is in contrast to the findings in our study [5, 19]. Our observation needs to be interpreted with care since the number of isolates analysed in the current study is smaller than previous studies, hence, comparing the rates of antimicrobials resistance may not give a true reflection of the real situation. However, in general all major isolates exhibited high resistance to chloramphenicol.

The high rates of resistance to chloramphenicol, cotrimoxazole and nalidixic acid by major gram-negative organisms in the study is of concern as we observed a large population of patients affected during the study period. This is of importance as studies have shown an increased risk of subsequent infection and mortality after hospital discharge following colonisation with drug resistant gram-negative bacteria [36]. Whilst drug resistant Gram-negative bacteria are recognised as a global problem in resource limited countries, the threat is much higher in areas with poor healthcare infrastructure and poor surveillance for antimicrobial resistance.

According to the Malawi Standard Treatment Guidelines, the antimicrobials used in the study are essential in the treatment of several conditions including sepsis, chronic diarrhoea and infant bacillary dysentery respectively [37]. In addition, cotrimoxazole is used as a prophylactic treatment for bacterial infections in HIV positive clients in the WHO clinical stages II, III and IV [37]. Overall, it is encouraging that ciprofloxacin proved to be relatively effective against most pathogens. In Malawi, ciprofloxacin is used in the treatment of bacillary dysentery in adults, sepsis, and also as a prophylactic treatment for meningococcal meningitis in adults [37].

Limitations

Some of the limitations of this study include lack of patient history on previous antimicrobial use. Consequently, this might have an influence on the observed rate of antimicrobial resistance. Secondly, due to limited availability of raw data, we were not able to capture an in-depth analysis of critical epidemiological data such as name of referral hospitals for the patients, onset of disease, occupation, and HIV status. The study was conducted at one tertiary hospital in northern Malawi as such the findings cannot be generalized to the whole country. Lastly, laboratory data on pathogen isolation, identification and susceptibility testing was generated using conventional methods, hence the results may be limited. Nevertheless, this study has provided an awareness on common microorganism isolated in our set up, their distributions and antimicrobial resistance pattern. This data could help practitioners and policy makers to make informed decisions on management of patients.

Conclusions

As a result of several social and public health interventions, Malawi has over the years recorded a marked decline in the incidence of bacterial bloodstream infections [5]. However, this study has demonstrated an increase in bacteria burden in sites other than blood stream as well as a concurrent increase in prevalence of antimicrobial resistance. The increased rates of antimicrobial resistance revealed in the study could be due to poor clinical practices or irrational use of antibiotics by the public. Nevertheless, to fight against antimicrobial resistance, a local epidemiological surveillance program is needed to guide in the generation of evidence-based guidelines for the treatment and management of bacterial infections.

Availability of data and materials

All data related to this study can be accessed at Mzuzu Central hospital upon consent is given from the authorities.

Abbreviations

AMR:

Antimicrobial Resistance

BAP:

Blood Agar Plate

CAP:

Chocolate Agar Plate

CSF:

Cerebral Spinal Fluid

ESBL:

Extended Spectrum beta-lactamase

MAP:

MacConkey Agar Plate

MCH:

Mzuzu Central Hospital

MRSA :

Methicillin Resistant Staphylococcus aureus

NHSRC:

National Health Science Research Committee

OPD:

Out Patient Department

sSA:

Sub-Saharan Africa

UKNEQAS:

UK National External Quality Assessment System

ZIMQAP:

Zimbabwe Quality Assurance Program

References

  1. 1.

    Troeger C, et al. Estimates of the global, regional, and national morbidity, mortality, and aetiologies of lower respiratory infections in 195 countries, 1990–2016: a systematic analysis for the global burden of disease study 2016. Lancet Infect Dis. 2018;18(11):1191–210.

    Article  Google Scholar 

  2. 2.

    WHO. World health statistics 2016: monitoring health for the SDGs sustainable development goals. Geneva: World Health Organization; 2016.

  3. 3.

    Byarugaba D. Antimicrobial resistance in developing countries and responsible risk factors. Int J Antimicrob Agents. 2004;24(2):105–10.

    CAS  PubMed  Article  Google Scholar 

  4. 4.

    Kariuki S, Dougan G. Antibacterial resistance in sub-Saharan Africa: an underestimated emergency. Ann N Y Acad Sci. 2014;1323(1):43.

    PubMed  PubMed Central  Article  Google Scholar 

  5. 5.

    Musicha P, et al. Trends in antimicrobial resistance in bloodstream infection isolates at a large urban hospital in Malawi (1998–2016): a surveillance study. Lancet Infect Dis. 2017;17(10):1042–52.

    PubMed  PubMed Central  Article  Google Scholar 

  6. 6.

    Mbanga J, Dube S, Munyanduki H. Prevalence and drug resistance in bacteria of the urinary tract infections in Bulawayo province, Zimbabwe. East Afr J Public Health. 2010;7(3):229–32.

  7. 7.

    Attram N, et al. Antimicrobial resistance (AMR) and molecular characterization of Neisseria gonorrhoeae in Ghana, 2012-2015. PLoS One. 2019;14(10):e0223598.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  8. 8.

    Williams PC, Isaacs D, Berkley JA. Antimicrobial resistance among children in sub-Saharan Africa. Lancet Infect Dis. 2018;18(2):e33–44.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  9. 9.

    Michael CA, Dominey-Howes D, Labbate M. The antimicrobial resistance crisis: causes, consequences, and management. Front Public Health. 2014;2:145.

    PubMed  PubMed Central  Article  Google Scholar 

  10. 10.

    Cheesbrough M. District laboratory practice in tropical countries. Tropical Health Technology, Norfolk: Cambridge university press; 2006.

  11. 11.

    Daoud Z, et al. Escherichia coli isolated from urinary tract infections of Lebanese patients between 2005 and 2012: epidemiology and profiles of resistance. Front Med. 2015;2:26.

    Google Scholar 

  12. 12.

    CLSI. Performance standards for antimicrobial susceptibility testing. In: Twenty-Second Informational Supplement ed, vol. 32. Wayne, PA: Clinical and Laboratory Standard Institute, CLSI document M100-S22; 2012.

    Google Scholar 

  13. 13.

    Feasey NA, Houston A, Mukaka M, Komrower D, Mwalukomo T, Tenthani L, et al. A reduction in adult blood stream infection and case fatality at a large African hospital following antiretroviral therapy roll-out. PLoS One. 2014;9(3):e92226.

  14. 14.

    Feasey NA, et al. Drug resistance in Salmonella enterica ser. Typhimurium bloodstream infection, Malawi. Emerg Infect Dis. 2014;20(11):1957.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  15. 15.

    Iroh Tam P-Y, et al. Emerging resistance to empiric antimicrobial regimens for pediatric bloodstream infections in Malawi (1998–2017). Clin Infect Dis. 2019;69(1):61–8.

    PubMed  Article  CAS  Google Scholar 

  16. 16.

    Archibald LK, et al. Epidemiology of bloodstream infections in a bacille Calmette-Guerin-vaccinated pediatric population in Malawi. J Infect Dis. 2003;188(2):202–8.

    PubMed  Article  Google Scholar 

  17. 17.

    Peters RP, et al. A prospective study of bloodstream infections as cause of fever in Malawi: clinical predictors and implications for management. Tropical Med Int Health. 2004;9(8):928–34.

    Article  Google Scholar 

  18. 18.

    NORTON EB, et al. Clinical predictors of bloodstream infections and mortality in hospitalized Malawian children. Pediatr Infect Dis J. 2004;23(2):145–51.

    PubMed  Article  Google Scholar 

  19. 19.

    Makoka MH, et al. Bacterial infections in Lilongwe, Malawi: aetiology and antibiotic resistance. BMC Infect Dis. 2012;12(1):67.

    PubMed  PubMed Central  Article  Google Scholar 

  20. 20.

    Komolafe O, et al. Bacteriology of burns at the queen elizabeth central hospital, Blantyre, Malawi. Burns. 2003;29(3):235–8.

    CAS  PubMed  Article  Google Scholar 

  21. 21.

    Maina D, Omuse G, Gunturu Revathi RDA. Spectrum of microbial diseases and resistance patterns at a private teaching hospital in Kenya: implications for clinical practice. PLoS One. 2016;11(1):e0147659.

  22. 22.

    Okesola A, Kehinde A. Bacteriology of non-surgical wound infections in Ibadan, Nigeria. Afr J Med Med Sci. 2008;37(3):261–4.

    CAS  PubMed  Google Scholar 

  23. 23.

    Biadglegne F, Abera B, Alem A, Anagaw B. Bacterial isolates from wound infection and their antimicrobial susceptibility pattern in Felege Hiwot referral Hospital North West Ethiopia. Ethiop J Health Sci. 2009;19(3):1029–857.

  24. 24.

    Moremi N, Claus H, Mshana SE. Antimicrobial resistance pattern: a report of microbiological cultures at a tertiary hospital in Tanzania. BMC Infect Dis. 2016;16(1):756.

    PubMed  PubMed Central  Article  CAS  Google Scholar 

  25. 25.

    Tong SY, et al. Staphylococcus aureus infections: epidemiology, pathophysiology, clinical manifestations, and management. Clin Microbiol Rev. 2015;28(3):603–61.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  26. 26.

    Rennie RP, et al. Occurrence and antimicrobial susceptibility patterns of pathogens isolated from skin and soft tissue infections: report from the SENTRY antimicrobial surveillance program (United States and Canada, 2000). Diagn Microbiol Infect Dis. 2003;45(4):287–93.

    CAS  PubMed  Article  Google Scholar 

  27. 27.

    Mordi R, Momoh M. Incidence of Proteus species in wound infections and their sensitivity pattern in the University of Benin Teaching Hospital. Afr J Biotechnol. 2009;8(5):1684–5315.

  28. 28.

    Perween N, Prakash SK, Siddiqui O. Multi drug resistant Klebsiella isolates in burn patients: a comparative study. J Clin Diagn Res. 2015;9(9):DC14.

    CAS  PubMed  PubMed Central  Google Scholar 

  29. 29.

    Oordt-Speets AM, Bolijn R, van Hoorn RC, Bhavsar A, Kyaw MH. Global etiology of bacterial meningitis: A systematic review and meta-analysis. PloS one. 2018;13(6):e0198772.

  30. 30.

    Mandomando I, et al. Antimicrobial drug resistance trends of bacteremia isolates in a rural hospital in southern Mozambique. Am J Trop Med Hyg. 2010;83(1):152–7.

    PubMed  PubMed Central  Article  Google Scholar 

  31. 31.

    Gajdács M. The continuing threat of methicillin-resistant Staphylococcus aureus. Antibiotics. 2019;8(2):52.

    PubMed Central  Article  CAS  Google Scholar 

  32. 32.

    Gordon SB, et al. Bacterial meningitis in Malawian adults: pneumococcal disease is common, severe, and seasonal. Clin Infect Dis. 2000;31(1):53–7.

    CAS  PubMed  Article  Google Scholar 

  33. 33.

    Carrol ED, et al. High pneumococcal DNA loads are associated with mortality in Malawian children with invasive pneumococcal disease. Pediatr Infect Dis J. 2007;26(5):416.

    PubMed  PubMed Central  Article  Google Scholar 

  34. 34.

    Molyneux E, et al. Dexamethasone treatment in childhood bacterial meningitis in Malawi: a randomised controlled trial. Lancet. 2002;360(9328):211–8.

    CAS  PubMed  Article  Google Scholar 

  35. 35.

    Gordon SB, et al. Pneumococcal disease in HIV-infected Malawian adults: acute mortality and long-term survival. AIDS (London, England). 2002;16(10):1409.

    Article  Google Scholar 

  36. 36.

    Tseng W-P, et al. Risk for subsequent infection and mortality after hospitalization among patients with multidrug-resistant gram-negative bacteria colonization or infection. Antimicrob Resist Infect Control. 2018;7(1):93.

    PubMed  PubMed Central  Article  Google Scholar 

  37. 37.

    Health, M.M.o, Malawi Standard Treatment Guidelines. 2015.

    Google Scholar 

Download references

Acknowledgements

We thank the research funding support from Pingtung Christian Hospital (Taiwan) through Luke International Malawi and with grant number:PS-IR-108001. Furthermore, the staff of Mzuzu Central Hospital and all the institutions involved for the technical support throughout research implementation process.

Funding

Pingtung Christian Hospital (Taiwan) through Luke International Malawi and with grant number:PS-IR-108001 funded this project. However, they had no role in the study design, data collection, analysis, interpretation of data and writing of the report and this manuscript.

Author information

Affiliations

Authors

Contributions

Study conception: MC, PK, MN, PSK, JW,; study design: MC, PK, MN, PSK, JW.; data collection: MC, PK, MN, PSK, PK, JW.; data analysis: MC, PK, PSK, ECA, EST, VCU; manuscript preparation: MC, PK, MN, PSK, PK, JW, ECA, EST, VCU. All the authors contributed adequately towards the completion of this study. Their career background played important roles. All authors read and approved the manuscript.

Corresponding author

Correspondence to Master R. O. Chisale.

Ethics declarations

Ethics approval and consent to participate

Ethical approval for the study was obtained from National Health Science Research Committee (NHSRC), (approval number NHSRC # 1206). The permission to access the raw data from was granted by the National Health Science Research Committee (NHSRC) and Mzuzu Central Hospital research ethics committee. No consent was obtained from individual participants since this was a retrospective study. However, the participant’s data was anonymized through use of serial numbers.

Consent for publication

None.

Competing interests

None.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Kumwenda, P., Adukwu, E.C., Tabe, E.S. et al. Prevalence, distribution and antimicrobial susceptibility pattern of bacterial isolates from a tertiary Hospital in Malawi. BMC Infect Dis 21, 34 (2021). https://doi.org/10.1186/s12879-020-05725-w

Download citation

Keywords

  • Antimicrobial resistance
  • Antibiotics
  • Prevalence
  • Susceptibility
  • Malawi